A carregar...
Biomarkers in dementia: clinical utility and new directions
Imaging, cerebrospinal fluid (CSF) and blood-based biomarkers have the potential to improve the accuracy by which specific causes of dementia can be diagnosed in vivo, provide insights into the underlying pathophysiology, and may be used as inclusion criteria and outcome measures for clinical trials...
Na minha lista:
| Publicado no: | J Neurol Neurosurg Psychiatry |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4335455/ https://ncbi.nlm.nih.gov/pubmed/25261571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2014-307662 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|